Muscle Cramp Pain Reliever Tablet
NDC Package 43689-0022-2
Package Information
Muscle Cramp Pain Reliever (causticum, colocynthis, cuprum metallicum, magnesia phosphorica, phytolacca decandra, rhus tox, stannum metallicum, veratrum album) tablets is temporarily relieves the symptoms of pain, stiffness and cramping in joints, legs, feet, hips and back. This formulation utilizes a tablet delivery system. Marketed by The Magni Company, this product is identified by NDC 43689-0022.
Identification & Billing
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 43689 - The Magni Company
- 43689-0022 - Muscle Cramp Pain Reliever
- 43689-0022-2 - 1 BOTTLE in 1 CARTON / 125 TABLET in 1 BOTTLE (43689-0022-1)
- 43689-0022 - Muscle Cramp Pain Reliever
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43689-0022-2 identifies a specific commercial package of 1 bottle in 1 carton / 125 tablet in 1 bottle (43689-0022-1) of Muscle Cramp Pain Reliever, a human over the counter drug labeled by The Magni Company. This tablet is formulated for oral use and contains causticum; citrullus colocynthis fruit pulp; copper; magnesium phosphate, dibasic trihydrate; phytolacca americana root; tin; toxicodendron pubescens leaf; veratrum album root as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Magni Company on September 18, 2019. The current certification is valid through December 31, 2026.
How is this The Magni Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43689002202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.